Capital Research Global Investors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Capital Research Global Investors’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-658,600	Closed	-$2.55M	–	451
2015 Q1	$2.55M	Hold	658,600	–	–	﹤0.01%	436
2014 Q4	$2.38M	Hold	658,600	–	–	﹤0.01%	435
2014 Q3	$1.75M	Hold	658,600	–	–	﹤0.01%	438
2014 Q2	$7.65M	Hold	658,600	–	–	﹤0.01%	420
2014 Q1	$9.2M	Buy	658,600 +208,600	+46%	+$3.28M	﹤0.01%	400
2013 Q4	$8M	Hold	450,000	–	–	﹤0.01%	411
2013 Q3	$7.58M	Buy	+450,000	New	+$6.32M	﹤0.01%	433

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors's MBII Position: Q2 2015 in Review

Capital Research Global Investors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2015, closing a stake of 658,600 shares — an estimated $2.55M sold.

Capital Research Global Investors first reported a position in MBII in Q3 2013 and held it in 7 quarters. The position peaked at $9.2M in Q1 2014. 38 funds tracked by Wall St. Rank hold MBII as of Q2 2015.

Capital Research Global Investors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2015 after selling out during the quarter.
Capital Research Global Investors sold 658,600 Marrone Bio Innovations, Inc. shares in Q2 2015, an estimated $2.55M.
Capital Research Global Investors first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and held it in 7 quarters.
Capital Research Global Investors's Marrone Bio Innovations, Inc. position peaked at $9.2M in Q1 2014.
38 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2015.

Based on Capital Research Global Investors's 13F filing for Q2 2015, filed 14 Aug 2015.